The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

See photos from this year's Summer Meeting.

Perinatal Guidelines Meeting

Book your place on the Perinatal Guidelines Meeting on 3rd October 2017
Read More

Summer Meeting 2018

Join us in London 22nd to 25th July 2018
Read More

Antidepressants and Suicide

Prof Carmine Pariante attended House of Commons Health Select Committee regarding antidepressants and suicide
Read More

Metabolic Guidelines Article

Article on the recent metabolic guidelines by Peter Haddad, Gavin Reynolds and Stephen Cooper
Read More

Fundamentals Wins BMA Award

Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Read More

Fundamentals of Clinical Psychopharmacology

Buy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Read More

Online CPD Resource

RCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Read More

New world order: Brexit, drugs and research

Letter to House of Commons Science and Technology Committee
Read More

The Ten Secrets of Success in Science

View Professor Trevor Robbins presenting his top tips
Read More

Neuroscience-based Nomenclature (NbN) for JoP

Journal of Psychopharmacology chosen to trial new NbN
Read More

Benefits of BAP membership include:

  • FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
  • Reduced registration fees for the annual Summer Meeting.
  • Half price subscription to the Online CPD Resource.
  • Eligibility for prizes and awards.
  • Student bursaries for the BAP Summer Meeting and international conferences.
  • Reduced registration fees for selected partner association events.
  • 50% OFF Royal Society of Biology membership (Read more)
  • BAP Newsletter.
  • Voting for BAP Officers and Council (full members only).
  • Being part of one of the largest national psychopharmacology associations in the world.

Meetings and Events

External Event BAP Session BAP Event BAP Stand

All Events

28th September 2017 Drug Treatments in Affective Disorders The International Centre for Life (Conferences), Newcastle upon Tyne
3rd October 2017 The Use of Psychotropic Medication Preconception, in Pregnancy and Postpartum - An introduction to the BAP Guidelines Hallam Conference Centre, 44 Hallam Street, London
5th October 2017 RCPsych Faculty of General Adult Psychiatry Annual Conference 2017 SAGE Gateshead, St Mary's Square, Gateshead Quays, Gateshead

Clinical Certificate | Masterclasses | Non-Clinical Certificate

Articles

SYMPOSIUM 2: The psychopharmacology of emerging calcium channel targets
By Nerissa Culi
Posted on 29th July 2017

Calcium ions (Ca2+) are universal intracellular messengers and, through selectively permeable calcium channels, can mediate and drive many important...


SHORT ORAL SESSION 1: Mechanisms of anxiety and its treatment
By Rebecca Lawson
Posted on 29th July 2017

The second to last sitting before the BAP conference dinner gave attendees the choice between three excellent short oral sessions. The mechanisms of anxiety...


SPECIAL SESSION: Challenges in managing depression
By Anahit Mkrtchian
Posted on 29th July 2017

The focus of this year’s special session was addressing different challenges faced by psychiatry in managing depression. First out was Prof Elias Eriksson...


See more articles

Media

Claire Gillan
What can big data do for mental health treatment?
Claire features in this blog about big data and it's role in improving prescribing of depression treatment
15th August 2017

Apo Aporoso
Is it safe to drink kava and drive?
Apo is interviewed by ABC News Australia on the effects of kava on driving
7th August 2017

Andrew Mayers
Jeremy Hunt announces ‘major’ recruitment in mental health
Andrew has written an article for the Dorset Eye with his response to the Health Secretary's plans to recruit almost 10,000 staff to mental health posts over the next 4 years
2nd August 2017

Val Curran
A framework for a regulated market for cannabis in the UK: Recommendations from an expert panel
Professor Val Curran was interviewed by World at One on the release of the cannabis framework
12th May 2017

Claire Gillan
Predicting the effectiveness of antidepressants
Dr Claire Gillan is creating an internet-based tool which could predict how effective antidepressants will be for different individuals
11th May 2017

See more media

News

Professor Trevor Robbins receives the 2017 Goldman-Rakic Award
4th July 2017

We are pleased to announce that Professor Trevor Robbins has been elected to receive the 2017 Goldman-Rakic Award
Read More
Bill Deakin to Receive 2017 BAP Lifetime Achievement Award
14th June 2017

We are delighted to announce that the recipient of the 2017 BAP Lifetime Achievement Award is Professor Bill Deakin from Manchester.
Read More
Perinatal Guidelines Meeting Now Open for Booking
12th May 2017

Book your place on the Perinatal Guidelines Meeting
Book your place
Perinatal Guidelines
27th April 2017

The new Perinatal Guidelines are now online.
View Guidelines

See more news

Twitter

Journal of Psychopharmacology

Most recent articles:

Serotonin and brain function: a tale of two receptors

Journal of Psychopharmacology, Volume 31, Issue 9, Page 1091-1120, September 2017.


Toward a multiscale modeling framework for understanding serotonergic function

Journal of Psychopharmacology, Volume 31, Issue 9, Page 1121-1136, September 2017.


Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis

Journal of Psychopharmacology, Volume 31, Issue 9, Page 1137-1148, September 2017.


Journal Website


Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.